ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study

ClinicalTrials.gov ID: NCT02585934

Public ClinicalTrials.gov record NCT02585934. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 11:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-blind, Randomized Study of RVT-101 Versus Placebo When Added to Existing Stable Donepezil Treatment in Subjects With Mild to Moderate Alzheimer's Disease

Study identification

NCT ID
NCT02585934
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axovant Sciences Ltd.
Industry
Enrollment
1,315 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • RVT-101 Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2015
Primary completion
Aug 31, 2017
Completion
Aug 31, 2017
Last update posted
Dec 4, 2018

2015 – 2017

United States locations

U.S. sites
61
U.S. states
19
U.S. cities
56
Facility City State ZIP Site status
US112 Phoenix Arizona 85005
US220 Tucson Arizona 85704
US168 Encino California 91436
US117 Fullerton California 92835
US214 Los Angeles California 90024
US189 Pasadena California 91105
US096 Rancho Mirage California 92270
US0195 Santa Ana California 92705
US016 Simi Valley California 93065
US106 Temecula California 92591
US179 Hamden Connecticut 06518
US171 Norwich Connecticut 06360
US088 Atlantis Florida 33462
US007 Brooksville Florida 34601
US002 Hallandale Florida 33009
US140 Hialeah Florida 33012
US216 Miami Florida 33137
US110 Miami Florida 33165
US172 North Palm Beach Florida 33408
US003 Orlando Florida 32806
US256 Pensacola Florida 32502
US037 Tampa Florida 33613
US042 Tampa Florida 33613
US004 The Villages Florida 32162
US048 Atlanta Georgia 30331
US046 Atlanta Georgia 30342
US217 Columbus Georgia 31909
US111 Baton Rouge Louisiana 70808
US095 Shreveport Louisiana 71104
US116 Newton Massachusetts 02459
US174 Quincy Massachusetts 02169
US144 Hattiesburg Mississippi 39401
US094 Las Vegas Nevada 89113
US135 Berlin New Jersey 08009
US197 Lawrenceville New Jersey 08648
US215 Mount Arlington New Jersey 07856
US057 Paterson New Jersey 08759
US209 Toms River New Jersey 08755
US036 West Long Branch New Jersey 07764
US001 Albany New York 12208
US049 Brooklyn New York 11235
US097 New Hyde Park New York 11040
US177 New Windsor New York 12553
US142 New York New York 10021
US044 New York New York 10022
US150 Chapel Hill North Carolina 27599
US185 Charlotte North Carolina 28270
US113 Beachwood Ohio 44122
US136 Cincinnati Ohio 45220
US008 Cincinnati Ohio 45227
US119 Shaker Heights Ohio 44122
US134 Portland Oregon 97210
US169 Media Pennsylvania 19063
US187 Philadelphia Pennsylvania 19102
US162 Plains Pennsylvania 18075
US148 Willow Grove Pennsylvania 19001
US115 Houston Texas 77074
US043 San Antonio Texas 78229
US143 Orem Utah 84058
US149 Charlottesville Virginia 22903
US170 Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 136 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02585934, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 4, 2018 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02585934 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →